When is the best time to zap brain tumors? new trial tests before, during, or after surgery
NCT ID NCT05871307
First seen May 06, 2026 · Last updated Jun 22, 2026 · Updated 5 times
Summary
This trial is testing three different timings for radiotherapy in people with brain metastases who need surgery: before surgery, during surgery, or after surgery. The goal is to see which approach best controls tumor growth and prevents recurrence. About 90 adults with solid tumors that have spread to the brain will take part. The study is active but not recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Radiotherapy, University of Heidelberg
Heidelberg, 69120, Germany
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Radiotherapy (stereotactic radiosurgery or intraoperative radiation)
What this could lead to
If successful, this trial could identify the optimal timing of radiotherapy for brain metastases, potentially improving local tumor control and reducing side effects.
What could go wrong
This is a small, early-phase (phase II) exploratory trial with only 90 participants. Results may not apply to all patients, and the best timing may still not be clear.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.